Waystone Advisors’s Cardinal Health CAH Stock Holding History

Waystone Advisors’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,174	Closed	-$248K	–	111
2026 Q1	$248K	Buy	+1,174	New	+$253K	0.22%	97

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Waystone Advisors's CAH Position: Q2 2026 in Review

Waystone Advisors sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 1,174 shares — an estimated $248K sold.

Waystone Advisors first reported a position in CAH in Q1 2026 and held it in 1 quarter. The position peaked at $248K in Q1 2026. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Waystone Advisors reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
Waystone Advisors sold 1,174 Cardinal Health shares in Q2 2026, an estimated $248K.
Waystone Advisors first reported a position in Cardinal Health in Q1 2026 and held it in 1 quarter.
Waystone Advisors's Cardinal Health position peaked at $248K in Q1 2026.
1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Waystone Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.